Case File №
#VI-2026-0406
Platinum Cryo
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
30 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Semaglutide | B Good | 6 | 6.1 | 5.2 | 8.0 | 22 Apr 2025 |
| Ipamorelin | C Okay | 6 | 5.6 | 4.8 | 6.5 | 22 Apr 2025 |
| Retatrutide | C Okay | 6 | 6.6 | 5.0 | 8.0 | 22 Apr 2025 |
| Melanotan II | E Bad | 6 | 4.1 | 2.0 | 7.0 | 22 Apr 2025 |
| 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | X N/A | 1 | 4.0 | 3.7 | 3.7 | 20 Jun 2025 |
| 17a-Methyl-1-Testosterone | X N/A | 1 | 6.9 | 6.9 | 6.9 | 11 Jun 2025 |
| Andarine (S-4) Raw | X N/A | 1 | 5.5 | 5.5 | 5.5 | 25 Apr 2025 |
| ARA-290 | X N/A | 1 | 5.7 | 5.7 | 5.7 | 24 Apr 2025 |
| BPC-157 Arg Oral | X N/A | 2 | 5.7 | 5.6 | 5.7 | 24 May 2026 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 4.0 | 2.0 | 2.0 | 13 Jun 2025 |
| Chonluten | X N/A | 1 | 4.0 | 3.7 | 3.7 | 21 May 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 2 | 5.3 | 4.6 | 6.0 | 20 May 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 2 | 5.6 | 5.5 | 5.7 | 17 May 2026 |
| EPO | X N/A | 2 | 7.2 | 6.0 | 8.3 | 21 May 2026 |
| Exemestane (Aromasin) Raw | X N/A | 2 | 4.0 | 3.1 | 4.2 | 17 May 2026 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 2 | 6.1 | 3.7 | 8.5 | 20 May 2026 |
| Methylene Blue | X N/A | 1 | 7.6 | 7.6 | 7.6 | 28 Mar 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 2 | 5.0 | 4.4 | 5.6 | 25 May 2026 |
| NA Semax Amidate | X N/A | 2 | 5.7 | 3.4 | 7.9 | 17 May 2026 |
| NAD+ | X N/A | 2 | 4.0 | 3.5 | 4.4 | 23 May 2026 |
| Nitroethane CAS 79-24-3 | X N/A | 2 | 7.0 | 6.5 | 7.4 | 24 May 2026 |
| P21 | X N/A | 2 | 5.6 | 3.2 | 8.0 | 25 May 2026 |
| PE 22-28 | X N/A | 1 | 8.7 | 8.7 | 8.7 | 25 Apr 2025 |
| Semax | X N/A | 1 | 5.2 | 5.2 | 5.2 | 24 Apr 2025 |
| SNAP-8 | X N/A | 1 | 4.0 | 3.3 | 3.3 | 21 May 2025 |
| Supertest 450 | X N/A | 1 | 5.8 | 5.8 | 5.8 | 6 May 2025 |
| Tadalafil Raw | X N/A | 2 | 5.0 | 4.4 | 5.5 | 17 May 2026 |
| Tirzepatide 30mg Pen Kit | X N/A | 1 | 5.8 | 5.8 | 5.8 | 27 Feb 2025 |
| Vilon | X N/A | 2 | 4.9 | 4.6 | 5.3 | 24 May 2026 |
| Winstrol (Stanozolol) | X N/A | 1 | 6.1 | 6.1 | 6.1 | 11 Jun 2025 |
Exhibit II
Evidence Log
46 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.1 B | 20mg | 22.6mg | +12.9% | 97.06% | iv2psc | Lab G | Public |
| 25 May 2026 | Exemestane (Aromasin) Raw | 4.8 C | 5g | 4.5g | -10.1% | 99.26% | 00mvc4 | Lab D | Community |
| 25 May 2026 | P21 | 4.8 C | 10mg | 11.1mg | +11.3% | 96.92% | jwcx9a | Lab A | Community |
| 24 May 2026 | Chonluten | 4.0 C | 2mg | 1.8mg | -11.1% | 96.56% | d75fad | Lab F | Community |
| 24 May 2026 | Supertest 450 | 4.0 C | 100mg/ml | 111.5mg/ml | +11.5% | 95.55% | 3qylf7 | Lab A | Community |
| 24 May 2026 | Tadalafil Raw | 4.0 C | 500g | 533.8g | +6.8% | 97.50% | 28sro0 | Lab A | Public |
| 24 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 5.0 B | 10mg | 9.7mg | -2.9% | 96.27% | 4x6849 | Lab C | Public |
| 24 May 2026 | Methylene Blue | 7.5 A | 25mg | 22.1mg | -11.6% | 97.63% | vnabpq | Lab A | Public |
| 23 May 2026 | BPC-157 Arg Oral | 5.6 B | 25mg | 28.5mg | +13.9% | 95.11% | jszqva | Lab C | Public |
| 23 May 2026 | EPO | 6.9 A | 5mg | 4.3mg | -14.0% | 99.67% | pt3dk0 | Lab F | Public |
| 23 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 4.0 C | 30mg | 31.2mg | +4.1% | 97.34% | 9olr5f | Lab B | Public |
| 23 May 2026 | Vilon | 5.1 B | 2mg | 2.4mg | +19.6% | 99.18% | omrpvn | Lab G | Public |
| 21 May 2026 | Nitroethane CAS 79-24-3 | 7.8 A | 1g | 1.2g | +17.9% | 98.46% | 1vwp3c | Lab D | Public |
| 20 May 2026 | NA Semax Amidate | 6.3 A | 2mg | 2.0mg | -1.1% | 95.21% | ltgvzu | Lab A | Community |
| 19 May 2026 | BPC-157 Arg Oral | 5.2 B | 50mg | 44.0mg | -11.9% | 98.71% | t3l340 | Lab G | Public |
| 19 May 2026 | N-Acetyl Epitalon Amidate | 4.3 C | 15mg | 13.2mg | -12.2% | 98.90% | 8l0eos | Lab C | Public |
| 19 May 2026 | NAD+ | 4.3 C | 10mg | 9.4mg | -6.4% | 97.90% | u5ycrm | Lab A | Public |
| 17 May 2026 | 17a-Methyl-1-Testosterone | 6.8 A | 50mg | 58.6mg | +17.2% | 96.36% | fkizjp | Lab G | Public |
| 29 Jan 2026 | Nitroethane CAS 79-24-3 | 6.4 A | 5g | 6.0g | +20.0% | 99.22% | zarsip | Lab F | Community |
| 26 Jan 2026 | Andarine (S-4) Raw | 6.7 A | 5g | 4.4g | -11.5% | 99.24% | q9ufuk | Lab G | Public |
| 26 Jan 2026 | NAD+ | 4.0 C | 30mg | 26.1mg | -13.1% | 95.80% | u5x9kf | Lab B | Community |
| 26 Jan 2026 | P21 | 4.4 C | 5mg | 4.5mg | -9.7% | 97.88% | o9uq66 | Lab G | Public |
| 9 Jan 2026 | ARA-290 | 6.4 A | 50mg | 42.9mg | -14.3% | 95.55% | dbdoer | Lab C | Public |
| 7 Jan 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 6.2 A | 10mg | 10.9mg | +9.2% | 98.02% | wzfp1h | Lab F | Community |
| 7 Jan 2026 | Tirzepatide 30mg Pen Kit | 5.7 B | 5mg | 5.9mg | +18.1% | 98.92% | w7woeg | Lab F | Community |
| 29 Dec 2025 | N-Acetyl Epitalon Amidate | 4.3 C | 20mg | 23.4mg | +17.2% | 97.28% | ysqon7 | Lab E | Public |
| 12 Dec 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.1 A | 10mg | 8.8mg | -11.8% | 95.79% | kutigu | Lab E | Public |
| 12 Dec 2025 | NA Semax Amidate | 7.3 A | 20mg | 24.2mg | +20.9% | 98.90% | 0jw28f | Lab A | Community |
| 12 Dec 2025 | Semax | 4.0 C | 50mg | 49.2mg | -1.6% | 98.06% | k5rjba | Lab A | Public |
| 12 Dec 2025 | Winstrol (Stanozolol) | 4.7 C | 20mg | 18.0mg | -10.0% | 97.07% | ctr99o | Lab G | Community |
| 5 Dec 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 4.0 C | 20mg | 20.9mg | +4.6% | 97.97% | gbbdcp | Lab F | Community |
| 14 Nov 2025 | Exemestane (Aromasin) Raw | 4.3 C | 5g | 4.9g | -2.4% | 95.32% | myifzb | Lab G | Public |
| 14 Nov 2025 | Vilon | 5.3 B | 2mg | 2.2mg | +9.0% | 95.80% | oce211 | Lab A | Public |
| 5 Nov 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.0 A | 10mg | 9.7mg | -3.1% | 97.37% | fax5ij | Lab G | Public |
| 5 Nov 2025 | PE 22-28 | 9.8 A | 30mg | 31.8mg | +5.9% | 97.82% | s3xry3 | Lab F | Community |
| 17 Oct 2025 | 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | 4.0 C | 5g | 5.8g | +16.7% | 99.12% | xc9kbs | Lab C | Public |
| 17 Oct 2025 | EPO | 6.9 A | 20mg | 18.5mg | -7.7% | 95.14% | aef8ev | Lab C | Public |
| 9 Oct 2025 | Tadalafil Raw | 4.9 C | 1g | 1.2g | +23.5% | 96.47% | 4zcj36 | Lab E | Community |
| 3 Oct 2025 | SNAP-8 | 4.4 C | 15mg | 18.6mg | +24.1% | 95.42% | nz2h6s | Lab B | Public |
| 8 May 2025 | Melanotan II | 7.0 A | 10mg | 9.79mg | -2.1% | 99.50% | (no batch ID) | Lab E | VendorInvestigator |
| 8 May 2025 | Melanotan II | 2.2 E | 10mg | 3.07mg | -69.3% | 98.81% | (no batch ID) | Lab E | VendorInvestigator |
| 7 May 2025 | Ipamorelin | 5.4 C | 5mg | 5.84mg | +16.8% | 100.00% | (no batch ID) | Lab E | VendorInvestigator |
| 7 May 2025 | Semaglutide | 5.6 C | 5mg | 5.05mg | +1.0% | 98.58% | (no batch ID) | Lab E | VendorInvestigator |
| 7 May 2025 | Retatrutide | 5.0 C | 15mg | 14.5mg | -3.3% | 97.30% | (no batch ID) | Lab E | VendorInvestigator |
| 7 May 2025 | Retatrutide | 5.0 C | 15mg | 14.3mg | -4.7% | 96.45% | (no batch ID) | Lab E | VendorInvestigator |
| 7 May 2025 | Ipamorelin | 6.1 B | 5mg | 5.36mg | +7.2% | 99.43% | (no batch ID) | Lab E | VendorInvestigator |
— END OF EVIDENCE LOG —